Radical prostatectomy in high-grade prostate cancer, salvage and adjuvant radiotherapy

Urologia Internationalis

Volumn 86, Issue 2, 2011, Pages 146-151

  Brodak, Milos ^a   Kosina, Josef ^a   Holub, Lukas ^a   Louda, Miroslav ^a   Odrazka, Karel ^b   Dolezel, Martin ^b   Sefrová, Jana ^a   Jansa, Jan ^a   Pacovsky, Jaroslav ^a  

^a UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

^b Pardubice Regional Hospital   (Czech Republic)

Author keywords

Adjuvant radiotherapy; Prostate cancer; Radical prostatectomy; Salvage radiotherapy

Indexed keywords

ANTIANDROGEN; ANTINEOPLASTIC AGENT;

ADULT; ADVERSE OUTCOME; ANTIANDROGEN THERAPY; ARTICLE; BONE METASTASIS; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER SURVIVAL; CANCER TISSUE; CAUSE OF DEATH; CLINICAL ARTICLE; COHORT ANALYSIS; ERECTILE DYSFUNCTION; FOLLOW UP; HEART INFARCTION; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INCONTINENCE; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROSTATE CANCER; PROSTATECTOMY; RETROSPECTIVE STUDY; SALVAGE THERAPY; TRANSURETHRAL RESECTION; URETHRA STRICTURE;

COHORT STUDIES; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; HUMANS; MALE; MEDICAL ONCOLOGY; NEOPLASM METASTASIS; PROSTATECTOMY; PROSTATIC NEOPLASMS; RADIOTHERAPY; RADIOTHERAPY, ADJUVANT; RECURRENCE; RETROSPECTIVE STUDIES; RISK; SALVAGE THERAPY; TREATMENT OUTCOME;

EID: 79952985646     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000320494     Document Type: Article

References (45)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ: Cancer Statistics 2008. CA Cancer J Clin 2008; 58: 71-96.
2. Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P: Estimates of cancer incidence and mortality in Europe in 2006. Ann Oncol 2007; 18: 581-592. (Pubitemid 46359643)
3. Do TM, Parker RG, Smith RB, Kagan AR: High-grade carcinoma of the prostate: a comparison of current local therapies. Urology 2001; 57: 1121-1126. (Pubitemid 32455583)
4. Köksal IT, Ozván F, Kadioglu TC, Esen T, Kilicaslan I, Tunc M: Discrepancy between scores of biopsy and radical prostatectomy specimen. Eur Urol 2000; 37: 670-674. (Pubitemid 30255783)
5. Billis A, Guimaraes MS, Freitas LL, Meirelles L, Magna LA, Ferreira U: The impact of the 2005 International Society of Urological Pathology Consensus Conference on standard Gleason grading of prostatic carcinoma in needle biopsies. J Urol 2008; 180: 548-552.
6. Rajinikanth A, Manoharan M, Soloway CT, Civantos FJ, Soloway MS: Trends in Gleason score: concordance between biopsy and prostatectomy over 15 years. Urology 2008; 72: 177-182.
7. Kral M, Student V, Kurf̈rstová, Vidlak A, Kucerova L: Gleason score in prostate biopsy and after radical prostatectomy - changes following ISUP 2005 and impact for urologist. Urolog pro Praxi 2007; 4: 173-178.
8. Capoun O, Babjuk M, Dvoracek J, Hanus T, Safarik L, Pavlik I: Prediction of the prostate cancer pathological classification. Ces Urol 2008; 12: 31-36.
9. Hes O, Hora M: Current approach to grading of the prostatic carcinoma: ISUP 2005 modification of Gleason system - review. Ces Urol 2007; 11: 112-114.
10. Kral M, Student V, Vidlak A, Hrabec M, Marek D: Predictive nomogram for Gleason score up-grading after prostate biopsy. Ces Urol 2007; 11: 82-86.
11. Van der Kwast TH, Bolla M, Van Poppel H, Van Cangh P, Vekemans K, Da Pozzo L: Identification of patients with prostate cancer who benefit from immediate postoperative radiotherapy: EORTC 22911. J Clin Oncol 2007; 25: 4178-4186. (Pubitemid 47548556)
12. Pasquier D, Ballereau C: Adjutant and salvage radiotherapy after prostatectomy for prostate cancer: a literature review. Int J Radiat Oncol Biol Phys 2008; 72: 972-979.
13. De Meerleer G, Fonteyne V, Meersschout S, Van den Broecke C, Villeirs G, Lumen N: Salvage intensity-modulated radiotherapy for rising PSA after radical prostatectomy. Radiother Oncol 2008; 89: 205-213.
14. Porter CR, Suardi N, Capitanio U, Hutterer GC, Kodama K, Gibbons RP, Correa R Jr, Perrotte P, Montorsi F, Karakiewicz PI: A nomogram predicting prostate cancer-specific mortality after radical prostatectomy. Urol Int 2010; 84: 132-140.
15. Bolla M, van Poppel H, Collette L, van Cangh P, Vekemans K, Da Pozzo L, de Reijke TM, Verbaeys A, Bosset JF, van Velthoven R, Maréchal JM, Scalliet P, Haustermans K, Piérart M: Postoperative radiotherapy after radical prostatectomy (EORTC trial 22911): A randomised controlled trial. Lancet 2005; 366: 572-578. (Pubitemid 41140332)
16. Bolla M, van Poppel H, Collette L: Preliminary results for EORTC trial 22911: radical prostatectomy followed by postoperative radiotherapy in prostate cancers with a high risk of progression. Cancer Radiother 2007; 11: 363-369. (Pubitemid 350110551)
17. Thompson I, Tangen C, Paradelo J, Lucia MS, Miller G, Troyer D, Messing E, Forman J, Chin J, Swanson G, Canby-Hagino E, Crawford ED: Adjuvant radiotherapy for pathologically advanced prostate cancer: A randomized Clinical Trial. JAMA 2006; 296: 2329-2335. (Pubitemid 44749360)
18. Swanson GP, Hussey MA, Tangen CM, Chin J, Messing E, Cangby-Hagino E, Forman JD, Thompson IM, Crawford ED: Predominant treatment failure in postprostatectomy patients is local: Analysis of patterns of treatment failure in SWOG 8794. J Clin Oncol 2007; 25: 2225-2229. (Pubitemid 46954647)
19. Wiegel T, Bottke D, Steiner U, Siegman A, Golz R, Störkel S, Willich N, Semjonow A, Souchon R, Stöckle M, R̈be C, Weissbach L, Althaus P, Rebmann U, Kälble T, Feldmann HJ, Wirth M, Hinke A, Hinkelbein W, Miller K: Phase III results of adjuvant radiotherapy (RT) versus 'wait and see' (WS) in patients with pT3 prostate cancer following radical prostatectomy (RP) (ARO 96-02/ AUO AP 09/95). J Clin Oncol 2009; 27: 2924-2930.
20. Cozzarini C, Bolognesi A, Ceresoli GL, Fiorino C, Rossa A, Bertini R, Colombo R, Da Pozzo L, Montorsi F, Roscigno M, Calandrino R, Rigatti P, Villa E: Role of postoperative radiotherapy after pelvic lymphadenectomy and radical retropubic prostatectomy: a single institute experience of 415 patients. Int J Radiat Oncol Biol Phys 2004; 59: 674-683. (Pubitemid 38748732)
21. Porter CR, Capitanio U, Perrotte P, Walz J, Isbarn H, Kodama K, Gibbons RP, Correa R Jr, Karakiewicz PI: Adjuvant radiotherapy after radical prostatectomy shows no ability to improve rates of overall and cancer-specific survival in a matched case-control study. BJU Int 2009; 103: 597-602.
22. Bastian PJ, Gonzalgo ML, Aronson WJ, Terris MK, Kane CJ, Amling CL, Presti JC Jr, Mangold LA, Humphreys E, Epstein JI, Partin AW, Freedland SJ: Clinical and pathologic outcome after radical prostatectomy for prostate cancer patients with preoperative Gleason sum of 8 to 10. Cancer 2006; 107: 1265-1272. (Pubitemid 44452775)
23. Manoharan M, Bird VG, Kim SS, Civantos F, Soloway MS: Outcome after radical prostatectomy with a pretreatment prostate biopsy Gleason score of 1 /=8. BJU Int 2003; 92: 539-544. (Pubitemid 37271725)
24. Stephenson AJ, Shariat SF, Zelefsky MJ, Kattan MW, Butler EB, Teh BS, Klein EA, Kupelian PA, Roehrborn CG, Pistenmaa DA, Pacholke HD, Liauw SL, Katz MS, Leibel SA, Scardino PT, Slawin KM: Salvage Radiotherapy for Recurrent Prostate Cancer after Radical Prostatectomy. JAMA 2004; 29: 1325-1332. (Pubitemid 38541647)
25. Cox JD, Gallagher MJ, Hammond EH, Kaplan RS, Schellhammer PF: American Society for Therapeutic Radiology and Oncology Consensus Panel. Consensus statements on radiation therapy of prostate cancer: guidelines for prostate re-biopsy after radiation and for radiation therapy with rising prostate- specific antigen levels after radical prostatectomy. J Clin Oncol 1999; 17: 1155-1163.
26. Tsien C, Griffith KA, Sandler HM, McLaughlin P, Sanda MG, Montie J, Reddy S, Hayman JA: Long-term results of three-dimensional conformal adjuvant and salvage radiotherapy after radical prostatectomy. Urology 2003; 62: 93-98. (Pubitemid 36802079)
27. Pacholke HD, Wajsman Z, Algood CB, Morris CG, Zlotecki RA: Postoperative adjuvant and salvage radiotherapy for prostate cancer: impact on freedom from biochemical relapse and survival. Urology 2004; 64: 982-986. (Pubitemid 39469518)
28. Hagan M, Zlotecki R, Medina C, Tercilla O, Rivera I, Wajsman Z: Comparison of adjuvant versus salvage radiotherapy policies for postprostatectomy radiotherapy. Int J Radiat Oncol Biol Phys 2004; 59: 329-340. (Pubitemid 38622583)
29. Cheung R, Kamat AM, de Crevoisier R, Allen PK, Lee AK, Tucker SL, Pisters L, Babaian RJ, Kuban D: Outcome of salvage radiotherapy for biochemical failure after radical prostatectomy with or without hormonal therapy. Int J Radiat Oncol Biol Phys 2005; 63: 134-140. (Pubitemid 41583551)
30. Monti CR, Nakamura RA, Ferrigno R, Rossi A, Kawakami NS, Trevisan FA: Salvage conformal radiotherapy for biochemical recurrent prostate cancer after radical prostatectomy. Int Braz J Urol 2006; 32: 416-426.
31. MacDonald OK, Schild SE, Vora S, Andrews PE, Ferrigni RG, Novicki DE, Swanson SK, Wong WW: Salvage radiotherapy for men with isolated rising PSA or locally palpable recurrence after radical prostatectomy: do outcomes differ? Urology 2004; 64: 760-764. (Pubitemid 39446058)
32. Brooks JP, Albert PS, Wilder RB, Gant DA, McLeod DG, Poggi MM: Long-term salvage radiotherapy outcome after radical prostatectomy and relapse predictors. J Urol 2005; 174: 2204-2208. (Pubitemid 41611774)
33. Song DY, Thompson TL, Ramakrishnan V, Harrison R, Bhavsar N, Onaodovan O, DeWeese TL: Salvage radiotherapy for rising or persistent PSA after radical prostatectomy. Urology 2002; 60: 281-287. (Pubitemid 34831773)
34. Bottke D, Wiegel T, Höcht S, M̈ller M, Schostak M, Hinkelbein W: Salvage radiotherapy in patients with persisting prostatespecific antigen after radical prostatectomy for prostate cancer. Oncology 2003; 65(suppl 1):18-23. (Pubitemid 37100175)
35. Lee LW, McBain CA, Swindell R., Wylie JP, Cowan RA, Logue JP: Hypofractionated radiotherapy as salvage for rising prostate-specificantigen after radical prostatectomy. Clin Oncol (R Coll Radiol) 2004; 16: 517-522. (Pubitemid 39517658)
36. Buskirk SJ, Pisansky TM, Schild SE, Macdonald OK, Wehle MJ, Kozelsky TF, Collie AC, Ferrigni RG, Myers RP, Prussak KA, Heckman MG, Crook JE, Parker AS, Igel TC: Salvage radiotherapy for isolated prostate specific antigen increase after radical prostatectomy: evaluation of prognostic factors and creation of a prognostic scoring system. J Urol 2006; 176: 985-990. (Pubitemid 44160708)
37. Wilder RB, Hsiang JY, Ji M, Earle JD, de Vere White R: Preliminary results of three-dimensional conformal radiotherapy as salvage treatment for a rising prostate-specific antigen level postprostatectomy. Am J Clin Oncol 2000; 23: 176-180.
38. Numata K, Azuma K, Hashine K, Sumiyoshi Y: Predictor of response to salvage radiotherapy in patients with PSA recurrence after radical prostatectomy: the usefulness of PSA doubling time. JPN J Clin Oncol 2005; 35: 256-259. (Pubitemid 41444291)
39. Xu Y, Liu R, Zhang Z, Hao Q, Qi S, Li J, Teng Z: Variables which might predict the response to salvage radiotherapy in chinese patients with biochemical failure after radical prostatectomy. Urol Int 2006; 77: 205-210. (Pubitemid 44567808)
40. Kurokawa K, Ito K, Suzuki K, Ono Y, Yamamoto T, Akimoto T, Yamanaka H: Salvage external beam radiotherapy for local recurrence without systemic progression or prostate specific antigen recurrence of prostate cancer after initial hormonal therapy: is it possible to identify patients likely to have good treatment outcomes? Jpn J Clin Oncol 2002; 32: 466-471. (Pubitemid 43102768)
41. Jacinto AA, Fede AB, Fagundes LA, Salvajoli JV, Castilho MS, Viani GA, Fogaroli RC, Novaes PE, Pellizzon AC, Maia MA, Ferrigno R: Salvage radiotherapy for biochemical relapse after complete PSA response following radical prostatectomy: outcome and prognostic factors for patients who have never received hormonal therapy. Radiat Oncol 2007; 2: 8-12.
42. Ward JF, Zincke H, Bergstralh EJ, Slezak JM, Blute ML: Prostate specific antigen doubling time subsequent to radical prostatectomy as a prognosticator of outcome following salvage radiotherapy. J Urol 2004; 172: 2244-2248. (Pubitemid 39507500)
43. Chawla AK, Thakral HK, Zietman AL, Shipley WU: Salvage radiotherapy after radical prostatectomy for prostate adenocarcinoma: analysis of efficacy and prognostic factors. Urology 2002; 59: 726-731. (Pubitemid 34461985)
44. Katz MS, Zelefsky MJ, Venkatraman ES, Fuks Z, Hummer A, Leibel SA: Predictors of biochemical outcome with salvage conformal radiotherapy after radical prostatectomy for prostate cancer. J Clin Oncol 2003; 21: 483-489. (Pubitemid 46606478)
45. Spahn M, Weiss C, Bader P, Ströbel P, Gerharz EW, Kneitz B, Frohneberg D: Longterm outcome of patients with high-risk prostate cancer following radical prostatectomy and stage-dependent adjuvant androgen deprivation. Urol Int 2010; 84: 164-173.